FDA Approves Pixclara (floretyrosine F 18) FET-PET Imaging Agent for Glioma

NDA FilingapprovedPixclaraPositive

AI Analysis

Summary

Telix announced FDA approval of Pixclara (floretyrosine F 18), a PET imaging agent for glioma detection. This represents a regulatory milestone for the company's diagnostic imaging portfolio.

Outcome Details

FDA approved New Drug Application for Pixclara (floretyrosine F 18) FET-PET imaging agent

Importance:8/10

Sentiment:

0.90

FDA approvalimaging agentoncologyPET imaging

Related Companies

$TLPPF

Read the original article

Published by Drugs.com New Drug Approvals on September 14, 2026 1:09 AM

Read Original